After establishing the disruptive effect of metastatic melanoma cells on endothelial monolayers and identifying IL-8 and VLA-4/VCAM-1 interactions as important triggers, we turned our attention to examining mechanistically how these tumor cell signals promote disruption of endothelial junctions. The gene discussed is VCAM1; the disease is neoplasm.